Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Agilent ( (A) ) has shared an update.
On March 31, 2026, Agilent Technologies announced that Senior Vice President, Chief Legal Officer and Secretary Bret DiMarco has entered into a transition agreement under which he will resign from these roles upon the earlier of the start date of a new Chief Legal Officer or September 30, 2026. He will then serve as a Special Advisor through December 1, 2026, receiving a reduced annualized base salary of $350,000, continued participation in health and welfare plans, and continued vesting of existing equity awards, but no new equity grants or 2026 annual bonus eligibility.
After completing his Special Advisor role, DiMarco will receive a lump-sum payment equal to one times his current base salary and target bonus, offset by the total base salary paid during his advisory period. The structured transition underscores Agilent’s effort to ensure continuity in its legal leadership while managing executive compensation commitments, providing stakeholders with visibility into the planned succession and the financial terms associated with the change in a key governance role.
The most recent analyst rating on (A) stock is a Buy with a $145.00 price target. To see the full list of analyst forecasts on Agilent stock, see the A Stock Forecast page.
Spark’s Take on A Stock
According to Spark, TipRanks’ AI Analyst, A is a Neutral.
The score is driven most by solid underlying fundamentals and a constructive earnings-call outlook (maintained growth guidance, raised EPS, and margin-expansion/tariff-mitigation plans). These positives are meaningfully offset by a weak technical setup (below key moving averages with negative momentum) and a relatively high P/E with a low dividend yield.
To see Spark’s full report on A stock, click here.
More about Agilent
Agilent Technologies, Inc. is a life sciences and analytical instruments company that provides laboratory solutions, including instruments, consumables, software, and services, to pharmaceutical, biopharma, chemical, environmental, and other scientific and industrial markets. The company focuses on supporting research, diagnostics, and quality control workflows across global laboratories and regulated industries.
Average Trading Volume: 2,274,767
Technical Sentiment Signal: Sell
Current Market Cap: $32.63B
For detailed information about A stock, go to TipRanks’ Stock Analysis page.